RBI Surprises with 25bps Repo Rate Cut to 625 Nomura Says Move Dilutes Policy Framework Geopolitical Tensions in Middle East Weigh on Asian Currencies as Oil Prices and US Dollar Surge Snowflake Stock Surges 36 on Earnings Beat and 6 Billion AWS Expansion Plan NATO Defense Spending Set to Surge as Trump Pledges 5000 Additional Troops to Poland Sojitz Expands Investment Focus to Australia and Uzbekistan Seeking New Growth Opportunities Single Premium Immediate Annuity Offering 91 Payout Attracts Retirees Seeking Income Stability BTSGU Q1 2026 Earnings Strong EPS Beat but Stock Declines Amidst Limited Revenue Disclosure Silo Pharma Inc SILO Q4 2023 Earnings Widening Losses as PreRevenue Biotech Focuses on Pipeline Progress VLYPP Q1 2026 Earnings Preferred EPS Beats Estimates Stock Declines Slightly XPEL Q1 2026 Earnings EPS Slightly Exceeds Estimates Shares Gain Ground CTS Q1 2026 Earnings Strong EPS Beat of 18 Drives Positive Stock Reaction Lotus Technology Inc LOT Q3 2025 Earnings Loss Per Share Reported Amid Limited Analyst Coverage AgomAb Therapeutics AGMB Advances 317 as Biotech Stock Nears Key Resistance Freightos Limited CRGO Edges Lower as Stock Tests Key Support Near 194 Rexford Industrial Realty REXR Navigates Resistance A Modest Pullback in a Consolidation Phase East West Bancorp EWBC Edges Lower as Shares Test Key Support Levels Dutch Bros BROS Drops 25 as Stock Tests Support Levels Amidst Volatile Sector CNBC Investment Club Trims Position After 46 Weekly Gain and 80 Surge Since April Investors Title Company ITIC Q4 2025 Earnings Strong EPS Performance Amid Quiet Period Corpay Inc CPAY Edges Higher Amid Steady Trading Spire Global Surges Over 10 as Momentum Builds Toward Key Resistance MillerKnoll Inc MLKN Holds Steady Near Support as Market Awaits Catalysts Apimeds Pharmaceuticals APUS Slides 423 Support Level in Focus BitMine Immersion Technologies BMNR Under Pressure as Shares Slide 372 New Concept Energy GBR Gains Ground Testing Key Resistance at 085 Zenas BioPharma ZBIO Rises 26 Testing Key Resistance at 1949 ImmuCell ICCC Slips Amidst Market Pressure Key Support Levels in Focus